Screener
Fulgent Genetics, Inc. FLGT Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total other income, net | 8,644 | 8,072 |
| Loss before income taxes | (25,978) | (11,723) |
| (Benefit from) provision for income taxes | (704) | 176 |
| Net loss from consolidated operations | (25,274) | (11,899) |
| Net loss attributable to noncontrolling interests | 448 | 369 |
| Net loss attributable to Fulgent | $(24,826) | $(11,530) |
| Net loss per common share attributable to Fulgent | ||
| Basic | $(0.80) | $(0.37) |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s net income?
- Fulgent Genetics, Inc. (FLGT) reported net income of -$25.27M in Q1 2026.
- How has Fulgent Genetics, Inc.'s net income changed year-over-year?
- Fulgent Genetics, Inc.'s net income decreased by 112.4% year-over-year, from -$11.9M to -$25.27M.
- What is the long-term trend for Fulgent Genetics, Inc.'s net income?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s net income has grown at a -40.9% compound annual growth rate (CAGR), from $506.24M to -$61.63M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Fulgent Genetics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude